D. Western Therapeutics Institute, Inc. (FRA:6DW)
Germany flag Germany · Delayed Price · Currency is EUR
0.5050
0.00 (0.00%)
Last updated: Feb 23, 2026, 8:12 AM CET

FRA:6DW Income Statement

Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
387.62471428448414
Revenue Growth (YoY)
-17.70%10.05%-4.46%8.21%16.62%
Cost of Revenue
38.8647362821
Gross Profit
348.76424392420393
Selling, General & Admin
298.86265258255248
Research & Development
669.781,367930469316
Operating Expenses
968.631,6341,190726565
Operating Income
-619.87-1,210-798-306-172
Interest Expense
-8.82-5-2-3-4
Interest & Investment Income
2.06----
Currency Exchange Gain (Loss)
7.92163317
Other Non Operating Income (Expenses)
-11.79-13-2-20-
EBT Excluding Unusual Items
-630.49-1,227-796-296-159
Gain (Loss) on Sale of Investments
---12-100-
Gain (Loss) on Sale of Assets
--2---
Asset Writedown
---6--
Legal Settlements
----44-
Other Unusual Items
--60-12--
Pretax Income
-630.49-1,289-826-440-159
Income Tax Expense
1.61111
Earnings From Continuing Operations
-632.09-1,290-827-441-160
Minority Interest in Earnings
--151212
Net Income
-632.09-1,290-812-429-148
Net Income to Common
-632.09-1,290-812-429-148
Shares Outstanding (Basic)
4835323029
Shares Outstanding (Diluted)
4835323029
Shares Change (YoY)
36.48%10.51%7.22%1.04%7.96%
EPS (Basic)
-13.19-36.73-25.55-14.47-5.05
EPS (Diluted)
-13.19-36.73-25.55-14.47-5.05
Free Cash Flow
-496.54-1,308-598-363-178
Free Cash Flow Per Share
-10.36-37.24-18.82-12.25-6.07
Gross Margin
89.98%90.02%91.59%93.75%94.93%
Operating Margin
-159.92%-256.90%-186.45%-68.30%-41.55%
Profit Margin
-163.07%-273.88%-189.72%-95.76%-35.75%
Free Cash Flow Margin
-128.10%-277.71%-139.72%-81.03%-42.99%
EBITDA
-572.35-1,161-750-260-127
EBITDA Margin
-147.66%-246.50%-175.23%-58.04%-30.68%
D&A For EBITDA
47.5249484645
EBIT
-619.87-1,210-798-306-172
EBIT Margin
-159.92%-256.90%-186.45%-68.30%-41.55%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.